Recombinant Semaphorin 4D (SEMA4D) Mus musculus (Mouse) Recombinant protein

CD100; A8; BB18; GR3; M-Sema G; M-Sema-G; SEMAJ; Coll-4; Sema Domain,Immunoglobulin Domain(Ig),Transmembrane Domain(TM)and Short Cytoplasmic Domain 4D

Add to Cart Distributors
Overview
Properties
  • Source Prokaryotic expression, Host E.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMembrane, Chromosome
  • Molecular Mass 16.4kDa, Accurate 16kDa(Analysis of differences refer to the manual)
  • Residues & TagsPhe502~Ser636 with N-terminal His Tag
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 95%
  • Isoelectric Point8.1
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Semaphorin 4D (SEMA4D) Packages (Simulation)
  • Recombinant Semaphorin 4D (SEMA4D) Packages (Simulation)
  • RPB430Mu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Sequence

Usage

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatmentPubmed:25395071
  • Genome-wide analysis identifies an african-specific variant in SEMA4D associated with body mass index.pubmed:28296344
  • A Revised Staging System for Waldenström's Macroglobulinemia10.1016/j.clml.2017.07.146
  • Extramedullary Multiple Myeloma: Clinical Features and Prognosis in Argentina10.1016/j.clml.2017.07.144
  • Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myelomaPubmed:29748532
  • A high-sensitivity enzyme immunoassay for the quantification of soluble human semaphorin 4D in plasmaPubmed: 30879960
  • Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitisPubmed: 32035658

Recommend products